G Louis Lange

Affiliations

  • at Newamsterdam Pharma Co N.v. (NAMS), 2024-02-21
  • Director at Epiphany Technology Acquisition Corp. (EPHY), 2022-10-04
  • Director at Bioplus Acquisition Corp. (BIOS), 2021-12-03
  • Director at Audentes Therapeutics Inc. (BOLD), 2020-01-15
  • Director at Cymabay Therapeutics Inc. (CBAY), 2015-06-30
  • Director at Esperion Therapeutics Inc. (ESPR), 2013-07-01
  • Director at Maxygen Inc (MAXY), 2012-06-07
  • Officer, Director at Cv Therapeutics Inc (CVTX), 2009-04-09
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
NAMS $19.00 5,000 24,878 2024-02-13 Filing
ESPR $14.00 10,714 Director 197,703 2013-07-01 Filing
ESPR $14.00 3,500 Director 17,814 2013-07-01 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
BOLD $59.60 1,000 Director 13,678 2019-12-23 Filing
BOLD $59.60 10,000 Director 265,799 2019-12-23 Filing
BOLD $32.18 1,000 Director 14,678 2019-09-23 Filing
BOLD $32.66 245 Director 275,799 2019-09-23 Filing
BOLD $32.15 9,755 Director 276,044 2019-09-23 Filing